Not available
Quote | Aduro Biotech Inc. (NASDAQ:ADRO)
Last: | $14.595 |
---|---|
Change Percent: | 4.18% |
Open: | $14.05 |
Close: | $14.595 |
High: | $14.8599 |
Low: | $13.92 |
Volume: | 170,695 |
Last Trade Date Time: | 10/05/2020 04:44:48 am |
News | Aduro Biotech Inc. (NASDAQ:ADRO)
The 15th Annual Global CSR & ESG Awards Honours 2023 Winners DA NANG, VIETNAM, Aug 30, 2023 - (ACN Newswire) - The 15th Annual Global CSR & ESG Summit & Awards ended on a high note before a full house in Da Nang, Vietnam, on August 28. Organized at the Novotel Danang Pre...
Combined Company Will H ave Over $275 Million in Operating Capital and Trade on Nasdaq under the Ticker Symbol “KDNY” VANCOUVER, British Columbia and SEATTLE, Oct. 05, 2020 (GLOBE NEWSWIRE) -- Chinook Therap...
Message Board Posts | Aduro Biotech Inc. (NASDAQ:ADRO)
Subject | By | Source | When |
---|---|---|---|
Nice run from 18 to 22 these past | nferna | investorshub | 10/27/2022 1:54:01 PM |
Symbol will be changing from $ADRO to KDNY | k9narc | investorshub | 10/06/2020 12:09:34 AM |
I expect it to, but that may be | k9narc | investorshub | 10/02/2020 7:42:46 PM |
do you think this may go up some | Newc | investorshub | 10/02/2020 5:37:56 PM |
The closing of the merger is anticipated to | k9narc | investorshub | 10/02/2020 3:56:04 PM |
News, Short Squeeze, Breakout and More Instantly...
Aduro Biotech Inc. Company Name:
ADRO Stock Symbol:
NASDAQ Market:
The 15th Annual Global CSR & ESG Awards Honours 2023 Winners DA NANG, VIETNAM, Aug 30, 2023 - (ACN Newswire) - The 15th Annual Global CSR & ESG Summit & Awards ended on a high note before a full house in Da Nang, Vietnam, on August 28. Organized at the Novotel Danang Pre...
Combined Company Will H ave Over $275 Million in Operating Capital and Trade on Nasdaq under the Ticker Symbol “KDNY” VANCOUVER, British Columbia and SEATTLE, Oct. 05, 2020 (GLOBE NEWSWIRE) -- Chinook Therap...
One-for-Five Reverse Stock Split to be Effective October 2, 2020 BERKELEY, Calif., Oct. 01, 2020 (GLOBE NEWSWIRE) -- Aduro Biotech, Inc. (NASDAQ: ADURO), a clinical-stage biopharmaceutical company focused on developing therapies targeting the Stimulator of Interferon Genes (ST...